Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| gamma-Cyclodextrins | 2 | 2020 | 2 | 1.240 |
Why?
|
| Cholesterol | 3 | 2020 | 232 | 1.210 |
Why?
|
| Niemann-Pick Disease, Type C | 3 | 2020 | 5 | 0.890 |
Why?
|
| Lysosomes | 2 | 2020 | 86 | 0.760 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 108 | 0.610 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 200 | 0.590 |
Why?
|
| Infant | 5 | 2023 | 1175 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2017 | 184 | 0.230 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2023 | 2 | 0.210 |
Why?
|
| Epilepsy | 1 | 2023 | 59 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 112 | 0.190 |
Why?
|
| beta-Cyclodextrins | 2 | 2018 | 35 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 42 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2021 | 91 | 0.170 |
Why?
|
| Hela Cells | 2 | 2018 | 376 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 20 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 48 | 0.160 |
Why?
|
| Biological Transport | 1 | 2020 | 204 | 0.150 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 1019 | 0.150 |
Why?
|
| Bronchiectasis | 1 | 2019 | 13 | 0.150 |
Why?
|
| Child | 4 | 2023 | 3443 | 0.150 |
Why?
|
| Mutism | 1 | 2019 | 1 | 0.150 |
Why?
|
| Infratentorial Neoplasms | 1 | 2019 | 1 | 0.150 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 4 | 0.150 |
Why?
|
| Proteomics | 2 | 2018 | 378 | 0.150 |
Why?
|
| Autophagy | 1 | 2020 | 140 | 0.150 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2018 | 5 | 0.150 |
Why?
|
| Cranial Sutures | 1 | 2018 | 2 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2018 | 3 | 0.150 |
Why?
|
| Craniotomy | 1 | 2018 | 5 | 0.150 |
Why?
|
| Endosomes | 1 | 2018 | 33 | 0.140 |
Why?
|
| Cyclodextrins | 1 | 2018 | 11 | 0.140 |
Why?
|
| Critical Care | 1 | 2018 | 49 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2020 | 321 | 0.140 |
Why?
|
| Cell Line | 2 | 2018 | 1410 | 0.140 |
Why?
|
| Protein Transport | 1 | 2018 | 296 | 0.130 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.130 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 5 | 0.130 |
Why?
|
| Fibrosarcoma | 1 | 2017 | 8 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 18 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 27 | 0.130 |
Why?
|
| Humans | 12 | 2024 | 43102 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 48 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2017 | 132 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 80 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1621 | 0.120 |
Why?
|
| Proteins | 1 | 2018 | 382 | 0.120 |
Why?
|
| Child, Preschool | 4 | 2023 | 1546 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 291 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2676 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2019 | 502 | 0.100 |
Why?
|
| Pteridines | 1 | 2013 | 3 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2013 | 4 | 0.100 |
Why?
|
| Neoplasms | 1 | 2024 | 1377 | 0.100 |
Why?
|
| Cytokines | 1 | 2017 | 678 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 159 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 140 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 257 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 241 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 495 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2544 | 0.080 |
Why?
|
| India | 2 | 2019 | 108 | 0.070 |
Why?
|
| Male | 4 | 2023 | 23409 | 0.070 |
Why?
|
| Female | 4 | 2020 | 24698 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2023 | 1604 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 1600 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 116 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1723 | 0.060 |
Why?
|
| Syncope | 1 | 2023 | 4 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2023 | 14 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2023 | 21 | 0.050 |
Why?
|
| Adolescent | 3 | 2023 | 6081 | 0.050 |
Why?
|
| Seizures | 1 | 2023 | 79 | 0.050 |
Why?
|
| Europe | 1 | 2019 | 115 | 0.040 |
Why?
|
| Genomics | 1 | 2021 | 293 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 52 | 0.040 |
Why?
|
| Netherlands | 1 | 2019 | 14 | 0.040 |
Why?
|
| Universities | 1 | 2023 | 559 | 0.040 |
Why?
|
| Indonesia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 26 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 780 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2018 | 20 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 33 | 0.040 |
Why?
|
| Skull | 1 | 2018 | 28 | 0.040 |
Why?
|
| Canada | 1 | 2019 | 163 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 87 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2018 | 30 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2018 | 44 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 734 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 2157 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 154 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 11 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 229 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 437 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 34 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2017 | 17 | 0.030 |
Why?
|
| Students | 1 | 2023 | 626 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 263 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 148 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2017 | 49 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 173 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 570 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 694 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 299 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 945 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 665 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 16992 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 358 | 0.030 |
Why?
|
| Mice | 2 | 2017 | 6644 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 51 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 158 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1070 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 508 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 347 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 1759 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 8214 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3994 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 12222 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 13872 | 0.010 |
Why?
|